Yuk L. Choi, Ph.D. - Publications

2011 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
1. Drug resistant of pathogenic bacteria. 2. Molecular virology of HIV and HBV.

105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Byeon S, Lee B, Park WY, Choi YL, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests. Clinical Lung Cancer. PMID 31839532 DOI: 10.1016/j.cllc.2019.11.006  0.4
2019 Park E, Choi YL, Ahn MJ, Han J. Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers. Pathology, Research and Practice. 152441. PMID 31085007 DOI: 10.1016/j.prp.2019.152441  0.4
2019 Kim YJ, Yu DB, Kim M, Choi YL. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma. Cancer Science. PMID 31069877 DOI: 10.1111/cas.14036  0.36
2018 Nam BD, Kim TJ, Park K, Ahn MJ, Choi YL, Chung MJ, Kim TS, Lee KS. Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients. Clinical Lung Cancer. PMID 30686681 DOI: 10.1016/j.cllc.2018.12.021  0.4
2018 Park HK, Kim M, Sung M, Lee SE, Kim YJ, Choi YL. Status of programmed death-ligand 1 expression in sarcomas. Journal of Translational Medicine. 16: 303. PMID 30400799 DOI: 10.1186/s12967-018-1658-5  0.36
2018 Kim Y, Lee B, Shim JH, Lee SH, Park WY, Choi YL, Sun JM, Ahn JS, Ahn MJ, Park K. Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30391576 DOI: 10.1016/j.jtho.2018.10.150  0.4
2018 Lee T, Choi S, Han J, Choi YL, Lee K. Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation. Journal of Pathology and Translational Medicine. PMID 30056636 DOI: 10.4132/jptm.2018.07.16  0.4
2018 Byeon S, Kim Y, Lim SW, Cho JH, Park S, Lee J, Sun JM, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ. Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30049203 DOI: 10.4143/crt.2018.151  0.4
2018 Lee J, Jung HA, Kim Y, Choi S, Han J, Choi YL, Lee SH, Ahn JS, Park K, Sun JM. Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma. Lung Cancer (Amsterdam, Netherlands). 122: 160-164. PMID 30032825 DOI: 10.1016/j.lungcan.2018.06.009  0.4
2017 Kwon MJ, Kim RN, Song K, Jeon S, Jeong HM, Kim JS, Han J, Hong S, Oh E, Choi JS, An J, Pollack JR, Choi YL, Park CK, Shin YK. Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer. Oncotarget. 8: 92209-92226. PMID 29190909 DOI: 10.18632/oncotarget.21150  0.4
2017 Oh DY, Jung K, Song JY, Kim S, Shin S, Kwon YJ, Oh E, Park WY, Song SY, Choi YL. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification. Bmc Cancer. 17: 535. PMID 28806950 DOI: 10.1186/s12885-017-3525-9  0.36
2017 Kim JM, Choi YL, Kim YJ, Park HK. Comparison and evaluation of risk factors for meningeal, pleural, and extrapleural solitary fibrous tumors: A clinicopathological study of 92 cases confirmed by STAT6 immunohistochemical staining. Pathology, Research and Practice. PMID 28552537 DOI: 10.1016/j.prp.2017.04.026  0.36
2017 Lee GD, Lee SE, Oh DY, Yu DB, Jeong HM, Kim J, Hong S, Jung HS, Oh E, Song JY, Lee MS, Kim M, Jung K, Kim J, Shin YK, ... Choi YL, et al. MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28502721 DOI: 10.1016/j.jtho.2017.04.031  0.36
2017 Park HK, Seo Y, Choi YL, Ahn MJ, Han J. Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy. Journal of Pathology and Translational Medicine. PMID 28372346 DOI: 10.4132/jptm.2016.10.18  0.4
2017 Lee MS, Jung EA, An SB, Kim YJ, Oh DY, Song JY, Um SW, Han J, Choi YL. Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28161936 DOI: 10.4143/crt.2016.347  0.4
2016 Cha YK, Lee HY, Ahn MJ, Park K, Ahn JS, Sun JM, Choi YL, Lee KS. The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations. Journal of Thoracic Disease. 8: 3175-3186. PMID 28066597 DOI: 10.21037/jtd.2016.11.25  0.4
2016 Choi ER, Lee HY, Jeong JY, Choi YL, Kim J, Bae J, Lee KS, Shim YM. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma. Oncotarget. PMID 27589833 DOI: 10.18632/oncotarget.11693  0.36
2016 Yu JI, Lee H, Park HC, Choi DH, Choi YL, Do IG, Kim HC, Lee WY, Yun SH, Cho YB, Huh JW, Park YA, Park YS, Park JO, Kim ST, et al. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget. PMID 27391438 DOI: 10.18632/oncotarget.10445  0.4
2016 Ahn S, Hwang SH, Han J, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ, Park W. Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases. Journal of Pathology and Translational Medicine. PMID 27160687 DOI: 10.4132/jptm.2016.04.19  0.4
2016 Yang L, Lee MS, Lu H, Oh DY, Kim YJ, Park D, Park G, Ren X, Bristow CA, Haseley PS, Lee S, Pantazi A, Kucherlapati R, Park WY, Scott KL, Choi YL, et al. Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing. American Journal of Human Genetics. 98: 843-856. PMID 27153396 DOI: 10.1016/j.ajhg.2016.03.017  0.4
2016 Lee SE, Oh E, Lee B, Kim YJ, Oh DY, Jung K, Choi JS, Kim J, Kim SJ, Yang JW, An J, Oh YL, Choi YL. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma. Oncotarget. PMID 27007161 DOI: 10.18632/oncotarget.8234  0.4
2016 Lee B, Lee T, Lee SH, Choi YL, Han J. Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers. Oncotarget. PMID 26992209 DOI: 10.18632/oncotarget.8074  0.4
2016 Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, Jiang L, Cheng J, Zheng G, Mao M. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare. Lung Cancer (Amsterdam, Netherlands). 94: 22-7. PMID 26973202 DOI: 10.1016/j.lungcan.2016.01.011  0.36
2016 Lee JK, Choi YL, Kwon M, Park PJ. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies. Annual Review of Pathology. PMID 26907526 DOI: 10.1146/annurev-pathol-012615-044446  0.4
2016 Kim N, Cho A, Watanabe H, Choi YL, Aziz M, Kassner M, Joung JG, Park AK, Francis JM, Bae JS, Ahn SM, Kim KM, Park JO, Park WY, Ahn MJ, et al. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. Oncotarget. PMID 26883194 DOI: 10.18632/oncotarget.7318  0.4
2016 Ham JS, Kim S, Kim HK, Byeon S, Sun JM, Lee SH, Ahn JS, Park K, Choi YL, Han J, Park W, Ahn MJ. Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: e1-4. PMID 26762749 DOI: 10.1016/j.jtho.2015.09.013  0.4
2015 Song HN, Jung KS, Yoo KH, Cho J, Lee JY, Lim SH, Kim HS, Sun JM, Lee SH, Ahn JS, Park K, Choi YL, Park W, Ahn MJ. Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26749488 DOI: 10.1016/j.jtho.2015.12.093  0.4
2015 Oh E, Choi YL, Kwon MJ, Kim RN, Kim YJ, Song JY, Jung KS, Shin YK. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples. Plos One. 10: e0144162. PMID 26641479 DOI: 10.1371/journal.pone.0144162  0.4
2015 Lim SH, Hong M, Ahn S, Choi YL, Kim KM, Oh D, Ahn YC, Jung SH, Ahn MJ, Park K, Zo JI, Shim YM, Sun JM. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. European Journal of Cancer (Oxford, England : 1990). 52: 1-9. PMID 26623522 DOI: 10.1016/j.ejca.2015.09.019  0.4
2015 Kwon MJ, Han J, Seo JH, Song K, Jeong HM, Choi JS, Kim YJ, Lee SH, Choi YL, Shin YK. CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer. Plos One. 10: e0139112. PMID 26444008 DOI: 10.1371/journal.pone.0139112  0.4
2015 Oh DY, Kim S, Choi YL, Cho YJ, Oh E, Choi JJ, Jung K, Song JY, Ahn SE, Kim BG, Bae DS, Park WY, Lee JW, Song S. HER2 as a novel therapeutic target for cervical cancer. Oncotarget. PMID 26435481 DOI: 10.18632/oncotarget.5283  0.36
2015 Park YH, Shin HT, Jung HH, Choi YL, Ahn T, Park K, Lee A, Do IG, Kim JY, Ahn JS, Park WY, Im YH. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer. Oncotarget. PMID 26397225 DOI: 10.18632/oncotarget.5184  0.4
2015 Cha JY, Wee J, Jung J, Jang Y, Lee B, Hong GS, Chang BC, Choi YL, Shin YK, Min HY, Lee HY, Na TY, Lee MO, Oh U. Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. PMID 26153424 DOI: 10.1073/pnas.1423827112  0.4
2015 Ahn JS, Ahn YC, Kim JH, Lee CG, Cho EK, Lee KC, Chen M, Kim DW, Kim HK, Min YJ, Kang JH, Choi JH, Kim SW, Zhu G, Wu YL, ... ... Choi YL, et al. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26150444 DOI: 10.1200/JCO.2014.60.0130  0.4
2015 Choi IH, Kim DW, Ha SY, Choi YL, Lee HJ, Han J. Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Positive Pulmonary Adenocarcinoma. Journal of Pathology and Translational Medicine. PMID 26095438 DOI: 10.4132/jptm.2015.05.13  0.4
2015 Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL, Shin YK. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo. International Journal of Molecular Sciences. 16: 12243-60. PMID 26035754 DOI: 10.3390/ijms160612243  0.4
2015 Choi MK, Hong JY, Chang WJ, Kim MJ, Kim SM, Jung HA, Do IG, Choi YL, Sun JM, Ahn JS, Park K, Ahn MJ. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test. Cancer Chemotherapy and Pharmacology. 75: 1229-36. PMID 25903122 DOI: 10.1007/s00280-015-2740-9  0.4
2015 Kim RN, Choi Y, Lee MS, Lira ME, Mao M, Mann D, Stahl J, Licon A, Choi SJ, Vrancken MV, Han J, Wlodarska I, Kim J. SEC31A-ALK Fusion Gene in Lung Adenocarcinoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25715771 DOI: 10.4143/crt.2014.254  0.4
2015 Lee J, Hong EC, Jeong H, Hwang JW, Kim H, Bae EK, Ahn JK, Choi YL, Han J, Cha HS, Koh EM. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model. International Journal of Rheumatic Diseases. 18: 514-23. PMID 25530272 DOI: 10.1111/1756-185X.12501  0.4
2015 Cha YK, Lee HY, Ahn MJ, Choi YL, Lee JH, Park K, Lee KS. Survival outcome assessed according to tumor burden and progression patterns in patients with epidermal growth factor receptor mutant lung adenocarcinoma undergoing epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clinical Lung Cancer. 16: 228-36. PMID 25499173 DOI: 10.1016/j.cllc.2014.11.002  0.4
2015 Song DH, Lee B, Shin Y, Choi IH, Ha SY, Lee JJ, Hong ME, Choi YL, Han J, Um SW. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations. Diagnostic Cytopathology. 43: 539-44. PMID 25427298 DOI: 10.1002/dc.23242  0.4
2015 Sun JM, Choi YL, Ji JH, Ahn JS, Kim KM, Han J, Ahn MJ, Park K. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 161-6. PMID 25355724 DOI: 10.1093/annonc/mdu504  0.4
2015 Kim SM, Kim MJ, Jung HA, Sun JM, Choi YL, Ko YH, Park K, Baek CH, Son YI, Ahn MJ. Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series. Head & Neck. 37: E66-9. PMID 25270523 DOI: 10.1002/hed.23884  0.4
2015 Jeong CJ, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma. Clinical Nuclear Medicine. 40: e34-9. PMID 25243942 DOI: 10.1097/RLU.0000000000000581  0.4
2015 Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, Mao M, Han J, Kim J, Choi YL. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 468-79. PMID 25234288 DOI: 10.1038/modpathol.2014.107  0.4
2015 Kim HS, Lee SE, Bae YS, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Jung DH, Shin SK, Lee SK, Lee YC, Kim HR, Moon YW, Kim JH, ... ... Choi YL, et al. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma Oncotarget. 6: 2562-2572.  0.4
2014 Yang HM, Choi HJ, Hong DP, Joo SY, Lee NE, Song JY, Choi YL, Lee J, Choi D, Kim B, Park HJ, Park JB, Kim SJ. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex. Experimental and Molecular Pathology. 97: 440-4. PMID 25281918 DOI: 10.1016/j.yexmp.2014.09.013  0.36
2014 Yoon HJ, Lee HY, Han J, Choi YL. Synchronous triple primary lung cancers: a case report. Korean Journal of Radiology. 15: 646-50. PMID 25246827 DOI: 10.3348/kjr.2014.15.5.646  0.4
2014 Bergamaschi A, Madak-Erdogan Z, Kim YJ, Choi YL, Lu H, Katzenellenbogen BS. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Research : Bcr. 16: 436. PMID 25213081 DOI: 10.1186/s13058-014-0436-4  0.36
2014 Jia L, Lee HS, Wu CF, Kundu J, Park SG, Kim RN, Wang LH, Erkin ÖC, Choi JS, Chae SW, Yang HB, Choi YL, Shin YK. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner. Molecular Cancer Research : McR. 12: 1779-95. PMID 25061104 DOI: 10.1158/1541-7786.MCR-14-0191  0.4
2014 Song DH, Choi IH, Ha SY, Han KM, Lee JJ, Hong ME, Choi YL, Jang KT, Song SY, Yi CA, Han J. Extrapulmonary lymphangioleiomyoma: clinicopathological analysis of 4 cases. Korean Journal of Pathology. 48: 188-92. PMID 25013416 DOI: 10.4132/KoreanJPathol.2014.48.3.188  0.4
2014 Lee B, Lee B, Han G, Kwon MJ, Han J, Choi YL. KRAS Mutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing. Korean Journal of Pathology. 48: 100-7. PMID 24868222 DOI: 10.4132/KoreanJPathol.2014.48.2.100  0.4
2014 Choi YL, Lira ME, Hong M, Kim RN, Choi SJ, Song JY, Pandy K, Mann DL, Stahl JA, Peckham HE, Zheng Z, Han J, Mao M, Kim J. A novel fusion of TPR and ALK in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 563-6. PMID 24736082 DOI: 10.1097/JTO.0000000000000093  0.4
2014 Kim YJ, Choi JS, Seo J, Song JY, Lee SE, Kwon MJ, Kwon MJ, Kundu J, Jung K, Oh E, Shin YK, Choi YL. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer. International Journal of Cancer. Journal International Du Cancer. 134: 2424-36. PMID 24615768 DOI: 10.1002/ijc.28566  0.4
2014 Chong Y, Kim JH, Lee HY, Ahn YC, Lee KS, Ahn MJ, Kim J, Shim YM, Han J, Choi YL. Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy? Plos One. 9: e88598. PMID 24586348 DOI: 10.1371/journal.pone.0088598  0.4
2014 Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. Ajr. American Journal of Roentgenology. 202: W224-33. PMID 24555618 DOI: 10.2214/AJR.13.11819  0.4
2014 Yoon H, Choi YL, Song JY, Do I, Kang SY, Ko YH, Song S, Kim BG. Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines. Plos One. 9: e88587. PMID 24523919 DOI: 10.1371/journal.pone.0088587  0.4
2014 Hong M, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 419-22. PMID 24518094 DOI: 10.1097/JTO.0000000000000061  0.4
2014 Kim HK, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Anticancer Research. 34: 707-14. PMID 24511003  0.4
2014 Ha SY, Choi IH, Han J, Choi YL, Cho JH, Lee KJ, Sun JM. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement. Lung Cancer (Amsterdam, Netherlands). 83: 411-5. PMID 24461304 DOI: 10.1016/j.lungcan.2013.12.015  0.4
2014 Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. The Journal of Molecular Diagnostics : Jmd. 16: 229-43. PMID 24418728 DOI: 10.1016/j.jmoldx.2013.11.007  0.4
2014 Park S, Lee J, Do IG, Jang J, Rho K, Ahn S, Maruja L, Kim SJ, Kim KM, Mao M, Oh E, Kim YJ, Kim J, Choi YL. Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling. Scientific Reports. 4: 3623. PMID 24406431 DOI: 10.1038/srep03623  0.36
2014 Park YH, Jung HA, Choi MK, Chang W, Choi YL, Do IG, Ahn JS, Im YH. Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment. British Journal of Cancer. 110: 384-91. PMID 24346286 DOI: 10.1038/bjc.2013.757  0.4
2014 Sun JM, Lira M, Pandya K, Choi YL, Ahn JS, Mao M, Han J, Park K, Ahn MJ, Kim J. Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 83: 259-64. PMID 24300132 DOI: 10.1016/j.lungcan.2013.11.009  0.4
2014 Kim J, Lee SH, Choi YL, Bae GE, Kim ES, Eoh W. Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment. European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 23: 27-31. PMID 24121750 DOI: 10.1007/s00586-013-3034-8  0.4
2014 Lee SE, Kim YJ, Kwon MJ, Choi DI, Lee J, Cho J, Seo SW, Kim SJ, Shin YK, Choi YL. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma. Histology and Histopathology. 29: 127-38. PMID 23852861  0.4
2013 Sun JM, Ahn MJ, Choi YL, Ahn JS, Park K. Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors. Lung Cancer (Amsterdam, Netherlands). 82: 294-8. PMID 24035188 DOI: 10.1016/j.lungcan.2013.08.023  0.4
2013 Sun JM, Kim JR, Do IG, Lee SY, Lee J, Choi YL, Ahn JS, Ahn MJ, Park K. A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer. British Journal of Cancer. 109: 1482-7. PMID 23963141 DOI: 10.1038/bjc.2013.467  0.4
2013 Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Annals of Surgical Oncology. 20: 3747-53. PMID 23800896 DOI: 10.1245/s10434-013-3070-y  0.4
2013 Sung CO, Choi CH, Ko YH, Ju H, Choi YL, Kim N, Kang SY, Ha SY, Choi K, Bae DS, Lee JW, Kim TJ, Song SY, Kim BG. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma. Cancer Genetics. 206: 145-53. PMID 23726144 DOI: 10.1016/j.cancergen.2013.04.002  0.4
2013 Kwon MJ, Seo J, Kim YJ, Kwon MJ, Choi JY, Kim TE, Lee DH, Park S, Shin YK, Han J, Choi YL. Prognostic significance of CD151 overexpression in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 81: 109-16. PMID 23570797 DOI: 10.1016/j.lungcan.2013.03.014  0.4
2013 Choi YL, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM. EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. Plos One. 8: e56011. PMID 23468851 DOI: 10.1371/journal.pone.0056011  0.4
2013 Sun JM, Rampal S, Lee G, Lee J, Choi YL, Parasuraman B, Guallar E, Cho J, Shim YM. Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 80: 191-6. PMID 23384673 DOI: 10.1016/j.lungcan.2013.01.009  0.4
2013 Park B, Jeong BC, Choi YL, Kwon GY, Lim JE, Seo SI, Jeon SS, Lee HM, Choi HY, Lee KS. Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue. Cancer Science. 104: 631-8. PMID 23384396 DOI: 10.1111/cas.12123  0.4
2013 Ha SY, Lee SE, Kwon MJ, Kim YJ, Lee EH, Seo J, Jang KT, Lee J, Choi YL. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Human Pathology. 44: 1300-9. PMID 23347652 DOI: 10.1016/j.humpath.2012.09.021  0.4
2013 Lira ME, Kim TM, Huang D, Deng S, Koh Y, Jang B, Go H, Lee SH, Chung DH, Kim WH, Schoenmakers EF, Choi YL, Park K, Ahn JS, Sun JM, et al. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. The Journal of Molecular Diagnostics : Jmd. 15: 51-61. PMID 23246132 DOI: 10.1016/j.jmoldx.2012.08.006  0.4
2013 Lee HY, Ahn HK, Jeong JY, Kwon MJ, Han JH, Sun JM, Ahn JS, Park K, Choi YL, Ahn MJ. Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 79: 40-5. PMID 23103072 DOI: 10.1016/j.lungcan.2012.10.002  0.4
2013 Kang YR, Park HY, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YL, Han J, Um SW. EGFR and KRAS mutation analyses from specimens obtained by bronchoscopy and EBUS-TBNA Thoracic Cancer. 4: 264-272. DOI: 10.1111/1759-7714.12006  0.4
2012 Noh JM, Park W, Huh SJ, Cho EY, Choi YL, Bae DS, Kim BG. Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients. Radiation Oncology Journal. 30: 218-25. PMID 23346542 DOI: 10.3857/roj.2012.30.4.218  0.4
2012 Sun JM, Choi YL, Won JK, Hirsch FR, Ahn JS, Ahn MJ, Park K. A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: e36-8. PMID 23154564 DOI: 10.1097/JTO.0b013e318274694e  0.4
2012 Yoon HJ, Lee HY, Lee KS, Choi YL, Ahn MJ, Park K, Ahn JS, Sun JM, Kim J, Kim TS, Chung MJ, Yi CA. Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications. Radiology. 265: 939-48. PMID 22929335 DOI: 10.1148/radiol.12112613  0.4
2012 Kundu J, Wahab SM, Kundu JK, Choi YL, Erkin OC, Lee HS, Park SG, Shin YK. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling. International Journal of Oncology. 41: 839-48. PMID 22710759 DOI: 10.3892/ijo.2012.1517  0.4
2012 Lee SE, Choi YL, Cho J, Kim T, Song SY, Sung CO. Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement: a case report and review of the literature. Human Pathology. 43: 1126-30. PMID 22305236 DOI: 10.1016/j.humpath.2011.10.008  0.4
2012 Park YH, Im SA, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Ahn JS, Im YH. Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy? Breast Cancer Research and Treatment. 133: 247-55. PMID 22270935 DOI: 10.1007/s10549-012-1956-1  0.4
2012 Lee SE, Lee EH, Park H, Sung JY, Lee HW, Kang SY, Seo S, Kim BH, Lee H, Seo AN, Ahn G, Choi YL. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. Human Pathology. 43: 1234-42. PMID 22245114 DOI: 10.1016/j.humpath.2011.09.012  0.4
2012 Kim T, Jung EA, Song JY, Roh JH, Choi JS, Kwon JE, Kang SY, Cho EY, Shin JH, Nam SJ, Yang JH, Choi YL. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast. Histopathology. 60: 347-56. PMID 22211293 DOI: 10.1111/j.1365-2559.2011.04072.x  0.36
2012 Park S, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histology and Histopathology. 27: 197-207. PMID 22207554 DOI: 10.14670/HH-27.197  0.4
2012 Kwon MJ, Kim ST, Kwon MJ, Kong DS, Lee D, Park S, Kang SY, Song JY, Nam DH, Kato Y, Choi YL, Suh YL. Mutated IDH1 is a favorable prognostic factor for type 2 gliomatosis cerebri. Brain Pathology (Zurich, Switzerland). 22: 307-17. PMID 21929658 DOI: 10.1111/j.1750-3639.2011.00532.x  0.36
2012 Jang HW, Lee JI, Kim HK, Oh YL, Choi YL, Jin DK, Kim JH, Chung JH, Kim SW. Identification of a cut-off for the MACIS score to predict the prognosis of differentiated thyroid carcinoma in children and young adults. Head & Neck. 34: 696-701. PMID 21748817 DOI: 10.1002/hed.21808  0.4
2011 Choi JW, Kim DG, Lee AE, Kim HR, Lee JY, Kwon NH, Shin YK, Hwang SK, Chang SH, Cho MH, Choi YL, Kim J, Oh SH, Kim B, Kim SY, et al. Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. Plos Genetics. 7: e1001351. PMID 21483803 DOI: 10.1371/journal.pgen.1001351  0.4
2011 Park K, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Experimental & Molecular Medicine. 43: 91-100. PMID 21200134 DOI: 10.3858/emm.2011.43.2.011  0.4
2011 Chang MH, Ahn HK, Lee J, Jung CK, Choi YL, Park YH, Ahn JS, Park K, Ahn MJ. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors. Cancer. 117: 143-51. PMID 20803614 DOI: 10.1002/cncr.25560  0.4
2010 Kim T, Choi YL, Park HY, Song JY, Shin JH, Nam SJ, Ahn G. Dermatofibrosarcoma protuberans of the breast skin. Pathology International. 60: 784-6. PMID 21091837 DOI: 10.1111/j.1440-1827.2010.02599.x  0.36
2010 Park HJ, Jang KT, Heo JS, Choi YL, Han J, Kim SH. A potential case of intraductal tubulopapillary neoplasms of the bile duct Pathology International. 60: 630-635. PMID 20712650 DOI: 10.1111/j.1440-1827.2010.02572.x  0.4
2010 Kim T, Sung CO, Song SY, Bae DS, Choi YL. FOXL2 mutation in granulosa-cell tumours of the ovary. Histopathology. 56: 408-10. PMID 20459545 DOI: 10.1111/j.1365-2559.2010.03487.x  0.4
2010 Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Research. 70: 2296-306. PMID 20215510 DOI: 10.1158/0008-5472.CAN-09-3141  0.4
2010 Jun HJ, Lee J, Lim DH, Park JO, Ahn G, Seo SW, Sung KS, Yoo KH, Choi YL. Expression of MET in alveolar soft part sarcoma Medical Oncology. 27: 459-465. PMID 19472090 DOI: 10.1007/s12032-009-9234-8  0.4
2009 Kang MK, Park W, Choi YL, Cho EY, Ahn G, Nam H, Huh SJ, Ahn YC, Lim DH, Oh DR, Bae DS, Kim BG. The effect of cyclooxygenase-2 expression on tumor volume response in patients treated with radiotherapy for uterine cervical cancer Journal of Korean Medical Science. 24: 1170-1176. PMID 19949677 DOI: 10.3346/jkms.2009.24.6.1170  0.4
2009 Sung CO, Ahn G, Song SY, Choi YL, Bae DS. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 28: 529-34. PMID 19851199 DOI: 10.1097/PGP.0b013e3181a2b8d3  0.4
2008 Cho EY, Han JJ, Choi YL, Kim KM, Oh YL. Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study. Journal of Korean Medical Science. 23: 1053-61. PMID 19119452 DOI: 10.3346/jkms.2008.23.6.1053  0.36
2007 Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK. Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2584-91. PMID 17473187 DOI: 10.1158/1078-0432.CCR-06-1785  0.4
2007 Choi YL, Lee SH, Kwon GY, Park CK, Han JJ, Jong SC, Han YC, Kim SH, Young KS. Overexpression of CD24: Association with invasiveness in urothelial carcinoma of the bladder Archives of Pathology and Laboratory Medicine. 131: 275-281. PMID 17284113 DOI: 10.1043/1543-2165(2007)131[275:OOCAWI]2.0.CO;2  0.4
2004 Choi YL, Park SH, Chung CK, Suh YL, Chi JG. Cortical laminar disorganization is correlated with severity of the cortical dysplasia and surgical outcome--experience with 150 cases. Epilepsy Research. 62: 171-8. PMID 15579305 DOI: 10.1016/j.eplepsyres.2004.09.004  0.4
2002 Gil MC, Lee MH, Seo JI, Choi YL, Kim MK, Jung KC, Park SH, Kim TJ. Characterization and epitope mapping of two monoclonal antibodies against human CD99. Experimental & Molecular Medicine. 34: 411-8. PMID 12526082 DOI: 10.1038/emm.2002.58  0.4
2000 Choi YL, Kim HS, Ahn G. Immunoexpression of inhibin α subunit, inhibin/activin βA subunit and CD99 in ovarian tumors Archives of Pathology and Laboratory Medicine. 124: 563-569. PMID 10747314 DOI: 10.1043/0003-9985(2000)124<0563:IOISIA>2.0.CO;2  0.4
Show low-probability matches.